ARL6IP5 and Parkinson disease: The extended studies we conducted on understanding the role of ARL6IP5 in Parkinson’s disease and aging revealed it was downregulated in the brain as it aged, and this downregulation was even more pronounced in PD animal, human, and cellular models.